Authors:
Pratschke, J
Wilhelm, MJ
Laskowski, I
Kusaka, M
Paz, D
Tullius, SG
Neuhaus, P
Hancock, WW
Tilney, NL
Citation: J. Pratschke et al., The influence of donor brain death on long-term function of renal allotransplants in rats, TRANSPLAN P, 33(1-2), 2001, pp. 693-694
Authors:
Reutzel-Selke, A
Tullius, SG
Zschockelt, T
Nieminen-Kelha, M
Bachmann, U
Jonas, S
Pratschke, J
Schmidbauer, G
Bechstein, WO
Volk, HD
Neuhaus, P
Citation: A. Reutzel-selke et al., Donor pretreatment of grafts from marginal donors improves long-term graftoutcome, TRANSPLAN P, 33(1-2), 2001, pp. 970-971
Authors:
Glanemann, M
Klupp, J
Langrehr, JM
Platz, KP
Schroer, G
Raakow, R
Stange, B
Settmacher, U
Bechstein, WO
Neuhaus, P
Citation: M. Glanemann et al., Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1069-1070
Authors:
Tullius, SG
Nieminen-Kelha, M
Reutzel-Selke, A
Bachmann, U
Jonas, S
Pratschke, J
Bechstein, WO
Volk, HD
Buelow, R
Neuhaus, P
Reinke, P
Citation: Sg. Tullius et al., Improvement of long-term function in renal allografts from 'marginal donors' following the induction of heme-oxygenase-1, TRANSPLAN P, 33(1-2), 2001, pp. 1160-1161
Authors:
Tullius, SG
Nieminen-Kelha, M
Bachmann, U
Reutzel-Selke, A
Jonas, S
Pratschke, J
Bechstein, WO
Reinke, P
Buelow, R
Neuhaus, P
Volk, HD
Citation: Sg. Tullius et al., Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allografts, TRANSPLAN P, 33(1-2), 2001, pp. 1286-1287
Authors:
Mueller, AR
Platz, KP
Willimski, C
Berg, T
Steinmuller, T
Neumann, U
Neuhaus, R
Hopf, U
Radke, C
Neuhaus, P
Citation: Ar. Mueller et al., Influence of immunosuppression on patient survival after liver transplantation for hepatitis C, TRANSPLAN P, 33(1-2), 2001, pp. 1347-1349
Authors:
Stange, B
Glanemann, M
Nussler, NC
Bechstein, WO
Neuhaus, P
Settmacher, U
Citation: B. Stange et al., Indication, technique, and outcome of portal vein arterialization in orthotopic liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1414-1415
Authors:
Pfitzmann, R
Langrehr, JM
Heise, M
Steinmuller, T
Neuhaus, R
Neuhaus, P
Citation: R. Pfitzmann et al., Successful orthotopic liver transplantation for treatment of intrahepatic Osler's disease, TRANSPLAN P, 33(1-2), 2001, pp. 1426-1427
Authors:
Langrehr, JM
Lohmann, R
Guckelberger, O
Muller, AR
Raakow, R
Nussler, NC
Klupp, J
Pfitzmann, R
Jonas, S
Settmacher, U
Steinmuller, T
Neuhaus, P
Citation: Jm. Langrehr et al., IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1433-1434
Authors:
Langrehr, JM
Klupp, J
Pfitzmann, R
Neumann, U
Lohmann, R
Jonas, S
Neuhaus, R
Steinmuller, T
Neuhaus, P
Citation: Jm. Langrehr et al., A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1520-1520
Authors:
Kahl, A
Bechstein, WO
Lorenz, F
Steinberg, J
Pohle, C
Kampf, D
Muller, A
Settmacher, U
Neuhaus, P
Frei, U
Citation: A. Kahl et al., Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil, TRANSPLAN P, 33(1-2), 2001, pp. 1694-1695
Authors:
Rayes, N
Seehofer, D
Schmidt, CA
Muller, AR
Steinmuller, T
Bechstein, WO
Neuhaus, P
Citation: N. Rayes et al., Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment?, TRANSPLAN P, 33(1-2), 2001, pp. 1804-1804
Authors:
Obermayer, N
Busse, B
Grunwald, A
Monch, E
Muller, C
Neuhaus, P
Gerlach, JC
Citation: N. Obermayer et al., Biochemical characterization of bioreactors for hybrid liver support: Serum-free liver cell coculture of nonparenchymal and parenchymal cells, TRANSPLAN P, 33(1-2), 2001, pp. 1930-1931
Authors:
Seehofer, D
Rayes, N
Naumann, U
Neuhaus, R
Muller, AR
Tullius, SG
Berg, T
Steinmuller, T
Bechstein, WO
Neuhaus, P
Citation: D. Seehofer et al., Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation, TRANSPLANT, 72(8), 2001, pp. 1381-1385
Authors:
Rayes, N
Seehofer, D
Schmidt, CA
Oettle, H
Muller, AR
Steinmuller, T
Settmacher, U
Bechstein, WO
Neuhaus, P
Citation: N. Rayes et al., Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation., TRANSPLANT, 72(5), 2001, pp. 881-885
Authors:
Pfitzmann, R
Heise, M
Langrehr, JM
Jonas, S
Steinmuller, T
Podrabsky, P
Ewert, R
Settmacher, U
Neuhaus, R
Neuhaus, P
Citation: R. Pfitzmann et al., Liver transplantation for treatment of intrahepatic Osler's disease: Firstexperiences, TRANSPLANT, 72(2), 2001, pp. 237-241
Authors:
Neumann, UP
Lang, M
Moldenhauer, A
Langrehr, JM
Glanemann, M
Kahl, A
Frei, U
Bechstein, WO
Neuhaus, P
Citation: Up. Neumann et al., Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation, TRANSPLANT, 71(8), 2001, pp. 1163-1168